| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
John Jefferies is Chief Medical Officer at DXR. John Jefferies's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $231K at current prices.
Net of sales, the DXR filings show accumulation of 8,285 shares.
John Jefferies has 3 Form 4 filings on record from November 2025 to August 2026, all as Chief Medical Officer at Daxor (DXR), 2025–2026.
The 4 reported transactions were 3 open-market purchases and 1 stock award.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.